Recombinant Mouse TNFSF15 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02114P-100UG
Mouse TNFSF15 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse TNFSF15 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02114P-100UG
Collections: Other recombinant proteins, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse TNFSF15 Protein is expressed from HEK293 with hFc tag at the N-Terminus.It contains Ala61-Leu252. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q5UBV8 |
Target Symbol | TNFSF15 |
Synonyms | TL1A; VEGI-251; TNFSF15; TL1; VEGI; VEGI192A |
Species | Mouse |
Expression System | HEK293 |
Tag | N-hFc |
Expression Range | Ala61-Leu252 |
Mol. Weight | The protein has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Mouse DR3, His Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Mouse TNFSF15, hFc Tag with the EC50 of 3.1ng/ml determined by ELISA (QC Test).. The affinity constant of 4.56 nM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | TL1A and its functional receptor DR3 are members of the TNF/TNFR superfamilies of proteins.TL1A and DR3 are abundantly localized at inflamed intestinal areas of patients with IBD and mice with experimental ileitis or colitis and actively participate in the immunological pathways that underlie mucosal homeostasis and intestinal inflammation.Recently, an important role was demonstrated for TL1A/DR3 as potential mediators of intestinal fibrosis that is associated with the presence of gut inflammation. |